Back
PIMCO Enhanced Short Maturity Active ESG Exch Tr Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
39
EMNT
PIMCO Enhanced Short Maturity Active ESG Exch Tr
Last Price:
$98.65
Seasonality Move:
-0.2%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$31.74
Seasonality Move:
-6.94%
Sell
39
PIMCO Enhanced Short Maturity Active ESG Exch Tr (EMNT)
is a Sell
Is PIMCO Enhanced Short Maturity Active ESG Exch Tr a Buy, Sell or Hold?
-
The current PIMCO Enhanced Short Maturity Active ESG Exch Tr [EMNT] share price is $98.65. The Score for EMNT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
EMNT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $31.58. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EMNT Stock Price Chart
What is PIMCO Enhanced Short Maturity Active ESG Exch Tr's stock price today?
-
The PIMCO Enhanced Short Maturity Active ESG Exch Tr share price today is $98.65The current trend is relatively stagnant and EMNT is experiencing selling pressure, which indicates risk of future bearish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $31.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing slight selling pressure.
EMNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.89 | Sell |
| Chaikin Money Flow: | -4304 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.57 - 98.73) | Buy |
| Bollinger Bands (100): | (98.57 - 98.79) | Sell |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.78 | Buy |
| Relative Strength Index (14 RSI): | 81.61 | Buy |
| Chaikin Money Flow: | -458148 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.71 - 29.31) | Buy |
| Bollinger Bands (100): | (3.38 - 18.1) | Buy |
EMNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 98.58 | Buy |
| 20-day SMA: | 98.65 | Sell |
| 50-day SMA: | 98.68 | Sell |
| 200-day SMA: | 98.62 | Buy |
| 8-day EMA: | 98.61 | Buy |
| 20-day EMA: | 98.64 | Buy |
| 50-day EMA: | 98.67 | Sell |
| 200-day EMA: | 98.64 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.26 | Buy |
| 20-day SMA: | 23.56 | Buy |
| 50-day SMA: | 14.96 | Buy |
| 200-day SMA: | 7.59 | Buy |
| 8-day EMA: | 28.43 | Buy |
| 20-day EMA: | 24.02 | Buy |
| 50-day EMA: | 17.44 | Buy |
| 200-day EMA: | 10.17 | Buy |
PIMCO Enhanced Short Maturity Active ESG Exch Tr Earnings Growth & EMNT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
PIMCO Enhanced Short Maturity Active ESG Exch Tr Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||